Yutaka Takahashi

Dr. Yutaka Takahashi


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 January 2019 in Oncotarget
Verified
Journal Article
Open access
PDF file
YTYutaka Takahashi
Yutaka Takahashi
TYTomohiro Yasui
Tomohiro Yasui
KMKazumasa Minami
Kazumasa Minami
KTKeisuke Tamari
Keisuke Tamari
KHKazuhiko Hayashi
Kazuhiko Hayashi
KOKazuhiko Ogawa
Kazuhiko Ogawa
Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma Carbon ion irradiation enhances the antitumor efficacy of dual immune checkpoint blockade therapy both for local and distant sites in murine osteosarcoma

18 December 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YTYutaka Takahashi
Yutaka Takahashi
TYTomohiro Yasui
Tomohiro Yasui
KTKeisuke Tamari
Keisuke Tamari
KMKazumasa Minami
Kazumasa Minami
KOKeisuke Otani
Keisuke Otani
KOKazuhiko Ogawa
Kazuhiko Ogawa
Radiation therapy has been long utilized as localized cancer treatment. Recent studies have also demonstrated that it has a distant effect by the enhanced immunity, but it rarely occurs. The purpose of this study was to investigate whether X-ray irradiation combined with anti-PD-L1 and anti-CTLA-4 antibodies (P1C4) provides a higher probability of this distant effect as well as enhanced local antitumor efficacy for osteosarcoma. LM8 mouse osteosarcoma cells were inoculated into both legs of C3H mice assigned to one of four groups, namely no treatment (No Tx), P1C4, X-ray irradiation (RAD) to the leg of one side, and combination (COMB) groups. Survival and treatment-related immune molecular changes were analyzed. Administration of P1C4 produced a tumor growth delay on day 30 in 18% of the mice. In contrast, combination therapy produced the strongest tumor growth inhibition not only at the irradiated tumor but also at unirradiated tumor in 67% of the mice. Accordingly, lung metastasis in the COMB group was strongly reduced by 98%, with a significant survival benefit. Unirradiated tumor in mice in the COMB group significantly recruited CD8 + tumor-infiltrating lymphocytes with a moderate reduction of Treg, producing a significant increase in the CD8/Treg ratio. These results suggest that radiation enhances the efficacy of P1C4 treatment against distant metastasis as well as local control in osteosarcoma. Our data suggest that radiation therapy combined with dual checkpoint blockade may be a promising therapeutic option for osteosarcoma.

29 April 1998 in Nephron
Verified
Journal Article
Closed access
PDF file
KTKyoichi Tashiro
Kyoichi Tashiro
SKSanki Kodera
Sanki Kodera
YTYutaka Takahashi
Yutaka Takahashi
Satoshi HorikoshiSatoshi Horikoshi
Satoshi Horikoshi
ISIsao Shirato
Isao Shirato
YTYasuhiko Tomino
Yasuhiko Tomino
The purpose of the present study was to determine the relationship between the existence of apoptotic cells in glomeruli, clinical or histopathological findings and response to treatment in patients with IgA nephropathy. Renal biopsy specimens were obtained from 23 patients with IgA nephropathy. These patients were divided into two groups: mild glomerular damage (12 patients), and severe glomerular damage (11 patients). The nick end-labelling method (TUNEL) and fluorescent staining (Hoechst 33258) were used for the detection of apoptotic cells. Five of 6 patients with apoptotic cells in the glomeruli detected by TUNEL were in the severe glomerular damage group, and only 1 patient was in the mild glomerular damage group. Apoptotic cells in glomeruli were also detected by fluorescent staining in 3 of 5 patients in the severe glomerular damage group who showed apoptotic cells in TUNEL. However, no apoptotic cells were detected in patients in the mild glomerular damage group in fluorescent staining. Mean levels of urinary protein excretion at the time of renal biopsy in the patients with apoptotic cells were significantly higher than those in patients without apoptotic cells (p < 0.01). The mean levels of creatinine clearance (Ccr) in the patients with apoptotic cells were slightly lower than those in patients without such cells. There were no significant differences in the levels of serum creatinine (s-Cr) and BUN in patients with or without apoptotic cells. In the severe glomerular damage group, urinary protein excretion after treatment in the patients with apoptotic cells was significantly improved compared with that in the patients without such cells (p < 0.01). It appears that the levels of proteinuria and renal function tests might be influenced by apoptosis in patients with IgA nephropathy. It is postulated that apoptosis may induce reduction of excess proliferative mesangial cells and/or infiltrated cells, and tissue repair. Thereafter, these histological alterations may improve proteinuria and renal function.

1 January 2014 in Journal of Industrial and Management Optimization
Verified
Journal Article
Open access
PDF file
THTsuguhito Hirai
Tsuguhito Hirai
HMHiroyuki Masuyama
Hiroyuki Masuyama
SKShoji Kasahara
Shoji Kasahara
YTYutaka Takahashi
Yutaka Takahashi
In cloud computing, a large-scale parallel-distributed processing service is provided where a huge task is split into a number of subtasks and those subtasks are processed on a cluster of machines called workers. In such a processing service, a worker which takes a long time for processing a subtask makes the response time long (the issue of stragglers). One of efficient methods to alleviate this issue is to execute the same subtask by another worker in preparation for the slow worker (backup tasks). In this paper, we consider the efficiency of backup tasks. We model the task-scheduling server as a single-server queue, in which the server consists of a number of workers. When a task enters the server, the task is split into subtasks, and each subtask is served by its own worker and an alternative distinct worker. In this processing, we explicitly derive task processing time distributions for the two cases that the subtask processing time of a worker obeys Weibull or Pareto distribution. We compare the mean response time and the total processing time under backup-task scheduling with those under normal scheduling. Numerical examples show that the efficiency of backup-task scheduling significantly depends on workers' processing time distribution.

15 April 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MYMasashi Yagi
Masashi Yagi
YTYutaka Takahashi
Yutaka Takahashi
KMKazumasa Minami
Kazumasa Minami
TMTaeko Matsuura
Taeko Matsuura
JNJin-Min Nam
Jin-Min Nam
KOKazuhiko Ogawa
Kazuhiko Ogawa
This study investigated variations in the relative biological effectiveness (RBE) values among various sarcoma and normal-tissue-derived cell lines (normal cell line) in proton beam and carbon-ion irradiations. We used a consistent protocol that specified the timing of irradiation after plating cells and detailed the colony formation assay. We examined the cell type dependence of RBE for proton beam and carbon-ion irradiations using four human sarcoma cell lines (MG63 osteosarcoma, HT1080 fibrosarcoma, SW872 liposarcoma, and SW1353 chondrosarcoma) and three normal cell lines (HDF human dermal fibroblast, hTERT-HME1 mammary gland, and NuLi-1 bronchus epithelium). The cells were irradiated with gamma rays, proton beams at the center of the spread-out Bragg peak, or carbon-ion beams at 54.4 keV/μm linear energy transfer. In all sarcoma and normal cell lines, the average RBE values in proton beam and carbon-ion irradiations were 1.08 ± 0.11 and 2.08 ± 0.36, which were consistent with the values of 1.1 and 2.13 used in current treatment planning systems, respectively. Up to 34% difference in the RBE of the proton beam was observed between MG63 and HT1080. Similarly, a 32% difference in the RBE of the carbon-ion beam was observed between SW872 and the other sarcoma cell lines. In proton beam irradiation, normal cell lines had less variation in RBE values (within 10%), whereas in carbon-ion irradiation, RBE values differed by up to 48% between hTERT-HME1 and NuLi-1. Our results suggest that specific dose evaluations for tumor and normal tissues are necessary for treatment planning in both proton and carbon-ion therapies.

12 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
WTWataru Takenaka
Wataru Takenaka
YTYutaka Takahashi
Yutaka Takahashi
KTKeisuke Tamari
Keisuke Tamari
KMKazumasa Minami
Kazumasa Minami
SKShohei Katsuki
Shohei Katsuki
KOKazuhiko Ogawa
Kazuhiko Ogawa
We previously reported that a combination of 10 Gy of X-ray irradiation and dual immune checkpoint blockade with anti-CTLA-4 (C4) and anti-PD-L1 antibodies produced a significant shrinkage of irradiated and unirradiated tumors (abscopal effect) and prolonged overall survival. However, the optimal radiation delivery regimen combined with single immune checkpoint blockade of C4 for inducing a maximum systemic antitumor response still remains unclear, particularly for patients with osteosarcoma. We used syngeneic C3H mice that were subcutaneously injected with LM8 osteosarcoma cells into both legs. C4 was administered three times, and one side of the tumor was irradiated by X-ray beams. The optimal radiation dose required to induce the abscopal effect was explored with a focus on the induction of the type-I interferon pathway. Radiation delivered in a single fraction of 10 Gy, 4.5 Gy × 3 fractions (fx), and 2 Gy × 8 fx with C4 failed to produce significant inhibition of unirradiated tumor growth compared with monotherapy with C4. Dose escalation to 16 Gy in a single fraction, or the equivalent hypofractionated dose of 8 Gy × 3 fx, which significantly increased secretion of IFN-β in vitro, produced a dramatic regression of both irradiated and unirradiated tumors and prolonged overall survival in combination with C4. Furthermore, irradiation at 16 Gy in both a single fraction and 8 Gy × 3 fx diminished regulatory T cells in the unirradiated tumor microenvironment. These results suggest that total dose escalation of radiation is crucial in C4 therapy to enhance the antitumor response in both local and distant tumors and prolonged overall survival regardless of fractionation for osteosarcoma.